SEC Form 4 · accession 0000885590-16-000112
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Clem Whitaker
Officer — EVP, Company Group Chairman
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2 | May 12, 2016 | A | 37,935 | $0.00 | A | 165,390 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents Restricted Share Units("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- F2One-third (1/3) of the RSUs will vest six months from the date of grant, one-third (1/3) of the RSUs will vest twelve months from the date of grant and one-third (1/3) of the RSUs will vest eighteen months from the date of grant, subject to continued employment through each vesting date.